Vera Therapeutics Inc. (VERA)

AI Score

Unlock

21.29

0.05 (0.24%)

At close: Apr 17, 2025, 3:59 PM

21.22

-0.35%

After-hours: Apr 17, 2025, 07:55 PM EDT

Vera Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Mar 31, 2020
Cash & Equivalents	92.65M	27.26M	25.09M	69.11M	45.68M	27.44M	33.89M	137.38M	43.46M	30.48M	50.43M	111.51M	79.67M	86.19M	91.63M	49.51M	53.65M	-3.23M
Short-Term Investments	548.21M	326.05M	359.3M	334.56M	115.03M	132.5M	147.13M	59.77M	71.19M	83.94M	81.5M	39.43M	867K	57K	85K	67K	86K	6.46M
Long-Term Investments	n/a	n/a	n/a	n/a	11K	13K	29K	57K	58K	122K	324K	580K	867K	1.11M	1.48M	293K	n/a	n/a
Other Long-Term Assets	131K	140K	5.7M	8.92M	6.95M	504K	465K	504K	455K	442K	375K	360K	344K	293K	293K	n/a	293K	-3.23M
Receivables	3.77M	n/a	1.96M	1.63M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.88M	472K	n/a
Other Current Assets	913K	3.13M	429K	568K	3.22M	1.92M	1.4M	883K	719K	792K	776K	759K	480K	786K	525K	1.43M	494K	n/a
Total Current Assets	651.22M	364.13M	389.5M	407.92M	165.54M	171.62M	190.61M	204.45M	125.7M	124.98M	142.34M	157.74M	82.54M	89.76M	95.88M	51.53M	54.26M	3.23M
Property-Plant & Equipment	4.33M	4.29M	2.08M	2.51M	3.04M	3.48M	4.07M	4.59M	5.22M	5.82M	5.75M	6.29M	n/a	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	4.46M	4.43M	7.79M	11.43M	10M	4M	4.56M	5.16M	5.74M	6.39M	6.44M	7.23M	1.21M	1.41M	1.77M	293K	293K	-3.23M
Total Assets	655.68M	368.56M	397.29M	419.36M	175.55M	175.62M	195.18M	209.6M	131.44M	131.37M	148.78M	164.97M	83.75M	91.17M	97.65M	51.83M	54.55M	n/a
Account Payables	7.67M	4.6M	4.66M	5.21M	11.12M	12.3M	13.28M	5.33M	11.99M	7.01M	7.08M	7.33M	1.39M	964K	1.72M	1.44M	909K	n/a
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.45M	n/a	n/a	n/a	n/a	n/a	533K	n/a
Short-Term Debt	n/a	n/a	2.12M	n/a	2.44M	2.52M	2.56M	2.6M	n/a	2.69M	2.45M	2.49M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	286K	6.83M	5.78M	2.38M	4.64M	6.43M	11.86M	7.75M	1.48M	4.07M	7.2M	4.85M	2.03M	1.49M	1.87M	960K	n/a
Total Current Liabilities	25.37M	26.46M	18.42M	14.54M	22.3M	24.62M	26.84M	23.53M	25.6M	15.92M	17.28M	19.97M	7.69M	4.04M	3.77M	3.75M	2.41M	n/a
Long-Term Debt	50.69M	50.47M	50.26M	50.07M	49.88M	25.04M	24.96M	24.89M	24.81M	4.97M	4.95M	4.94M	4.92M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	286K	286K	286K	286K	287K	286K	286K	286K	286K	286K	1.54M	1.65M	1.72M	141.39M	141.5M	n/a
Total Long-Term Liabilities	53.16M	53.04M	51M	51.27M	51.56M	27.29M	27.82M	28.37M	28.93M	9.73M	10M	10.58M	6.47M	1.65M	1.72M	141.39M	141.5M	n/a
Total Liabilities	78.53M	79.5M	69.42M	65.81M	73.86M	51.91M	54.66M	51.9M	54.53M	25.65M	27.28M	30.55M	14.16M	5.69M	5.49M	145.14M	143.9M	n/a
Total Debt	54.64M	54.91M	52.83M	53.26M	53.71M	29.52M	30.09M	30.68M	31.29M	12.13M	12.16M	12.78M	4.92M	n/a	n/a	n/a	2K	n/a
Common Stock	64K	55K	55K	54K	44K	44K	44K	44K	28K	28K	27K	27K	21K	21K	21K	n/a	n/a	n/a
Retained Earnings	-461.25M	-417.82M	-371.19M	-337.49M	-309.1M	-283.45M	-263.34M	-243.18M	-213.11M	-180.67M	-155.99M	-141.14M	-124.06M	-107.21M	-99.6M	-96.16M	-91.45M	n/a
Comprehensive Income	393K	1.04M	-450K	-173K	251K	-75K	-142K	-4K	-224K	-279K	-152K	-12K	-0.00	-91.17M	-97.65M	n/a	n/a	-36.55M
Shareholders Equity	577.15M	289.06M	327.87M	353.54M	101.69M	123.71M	140.52M	157.71M	76.91M	105.72M	121.5M	134.43M	69.59M	85.48M	92.16M	-93.32M	-89.35M	3.55M
Total Investments	548.21M	326.05M	359.3M	334.56M	115.05M	132.51M	33.92M	59.83M	71.25M	84.07M	81.83M	40.01M	1.73M	1.11M	1.48M	293K	86K	6.46M